Goldman Sachs’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31,495
| Closed | -$117K | – | 5256 |
|
|
2024
Q3 | $117K | Sell |
31,495
-47,598
| -60% | -$178K | ﹤0.01% | 4586 |
|
|
2024
Q2 | $443K | Sell |
79,093
-98,714
| -56% | -$553K | ﹤0.01% | 4018 |
|
|
2024
Q1 | $932K | Sell |
177,807
-16,017
| -8% | -$83.9K | ﹤0.01% | 3663 |
|
|
2023
Q4 | $1.01M | Buy |
193,824
+32,571
| +20% | +$170K | ﹤0.01% | 3612 |
|
|
2023
Q3 | $2.54M | Sell |
161,253
-53,977
| -25% | -$851K | ﹤0.01% | 2946 |
|
|
2023
Q2 | $4.18M | Buy |
215,230
+45,684
| +27% | +$888K | ﹤0.01% | 2688 |
|
|
2023
Q1 | $4.81M | Buy |
169,546
+27,652
| +19% | +$784K | ﹤0.01% | 2582 |
|
|
2022
Q4 | $4.15M | Buy |
141,894
+32,217
| +29% | +$942K | ﹤0.01% | 2761 |
|
|
2022
Q3 | $2.9M | Sell |
109,677
-55,905
| -34% | -$1.48M | ﹤0.01% | 3069 |
|
|
2022
Q2 | $7.36M | Sell |
165,582
-12,724
| -7% | -$565K | ﹤0.01% | 2364 |
|
|
2022
Q1 | $8.83M | Buy |
178,306
+70,438
| +65% | +$3.49M | ﹤0.01% | 2340 |
|
|
2021
Q4 | $5.49M | Buy |
107,868
+792
| +0.7% | +$40.3K | ﹤0.01% | 2723 |
|
|
2021
Q3 | $5.97M | Sell |
107,076
-90,686
| -46% | -$5.06M | ﹤0.01% | 2662 |
|
|
2021
Q2 | $8.46M | Buy |
197,762
+60,540
| +44% | +$2.59M | ﹤0.01% | 2378 |
|
|
2021
Q1 | $5.73M | Sell |
137,222
-10,947
| -7% | -$457K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $6.9M | Sell |
148,169
-18,697
| -11% | -$871K | ﹤0.01% | 2275 |
|
|
2020
Q3 | $7.09M | Buy |
166,866
+45,523
| +38% | +$1.93M | ﹤0.01% | 2172 |
|
|
2020
Q2 | $5.82M | Sell |
121,343
-205,950
| -63% | -$9.88M | ﹤0.01% | 2252 |
|
|
2020
Q1 | $15.1M | Buy |
327,293
+189,120
| +137% | +$8.7M | 0.01% | 1515 |
|
|
2019
Q4 | $8.3M | Buy |
138,173
+70,233
| +103% | +$4.22M | ﹤0.01% | 2139 |
|
|
2019
Q3 | $3.84M | Sell |
67,940
-38,412
| -36% | -$2.17M | ﹤0.01% | 2482 |
|
|
2019
Q2 | $5.92M | Sell |
106,352
-24,508
| -19% | -$1.36M | ﹤0.01% | 2220 |
|
|
2019
Q1 | $6.61M | Sell |
130,860
-31,597
| -19% | -$1.6M | ﹤0.01% | 2264 |
|
|
2018
Q4 | $6.55M | Sell |
162,457
-5,477
| -3% | -$221K | ﹤0.01% | 2155 |
|
|
2018
Q3 | $11.6M | Buy |
167,934
+47,819
| +40% | +$3.32M | ﹤0.01% | 1957 |
|
|
2018
Q2 | $9.09M | Buy |
120,115
+17,671
| +17% | +$1.34M | ﹤0.01% | 2055 |
|
|
2018
Q1 | $5.4M | Sell |
102,444
-6,413
| -6% | -$338K | ﹤0.01% | 2296 |
|
|
2017
Q4 | $5.82M | Buy |
108,857
+26,251
| +32% | +$1.4M | ﹤0.01% | 2214 |
|
|
2017
Q3 | $4.93M | Sell |
82,606
-22,175
| -21% | -$1.32M | ﹤0.01% | 2363 |
|
|
2017
Q2 | $8.27M | Sell |
104,781
-32,256
| -24% | -$2.54M | ﹤0.01% | 2020 |
|
|
2017
Q1 | $11.4M | Buy |
137,037
+96,536
| +238% | +$8.01M | ﹤0.01% | 1793 |
|
|
2016
Q4 | $3.21M | Buy |
40,501
+13,555
| +50% | +$1.08M | ﹤0.01% | 2440 |
|
|
2016
Q3 | $1.89M | Buy |
26,946
+12,096
| +81% | +$847K | ﹤0.01% | 2740 |
|
|
2016
Q2 | $576K | Sell |
14,850
-54,362
| -79% | -$2.11M | ﹤0.01% | 3240 |
|
|
2016
Q1 | $2.8M | Buy |
69,212
+61,390
| +785% | +$2.49M | ﹤0.01% | 2357 |
|
|
2015
Q4 | $694K | Buy |
7,822
+6,798
| +664% | +$603K | ﹤0.01% | 3081 |
|
|
2015
Q3 | $76K | Sell |
1,024
-17,074
| -94% | -$1.27M | ﹤0.01% | 4244 |
|
|
2015
Q2 | $1.46M | Buy |
18,098
+8,259
| +84% | +$668K | ﹤0.01% | 2754 |
|
|
2015
Q1 | $412K | Buy |
+9,839
| New | +$412K | ﹤0.01% | 3444 |
|